Laboratory tests for the antiphospholipid syndrome: current concepts

Area of Science:

• Immunology
• Clinical Chemistry
• Hematology

Background:

• Antiphospholipid syndrome (APS) diagnosis is crucial for effective treatment and improved patient outcomes.
• Clinical manifestations of APS lack specificity, necessitating accurate laboratory diagnostic tools.
• Current diagnostic assays for APS, including anticardiolipin (aCL) immunoassays and lupus anticoagulant (LA) clotting assays, face challenges with standardization, specificity, and sensitivity.

Purpose of the Study:

• To review the current landscape of antiphospholipid syndrome (APS) diagnosis.
• To discuss the limitations of existing laboratory methods for APS detection.
• To introduce and describe novel assays being developed as alternatives or supplements to current diagnostic standards.

Main Methods:

• Review of existing literature on antiphospholipid syndrome (APS) diagnostic assays.
• Description of principles behind established immunoassays (ELISA for aCL) and clotting assays (for LA).
• Introduction of newer diagnostic methodologies, including anti-beta-2-glycoprotein I ELISAs, antiprothrombin ELISAs, phospholipid mixture ELISAs, and modified clotting assays.

Main Results:

• Established assays for anticardiolipin (aCL) antibodies exhibit low specificity.
• Lupus anticoagulant (LA) assays demonstrate low sensitivity.
• Significant standardization issues persist for both current aCL and LA diagnostic methods.

Conclusions:

• There is a clear need for improved laboratory diagnostic methods for antiphospholipid syndrome (APS).
• Emerging assays targeting autoantibodies like anti-beta-2-glycoprotein I and antiprothrombin show promise.
• Further validation of novel diagnostic techniques is essential for enhancing APS detection and patient management.